Group 1 - POMDOCTOR LIMITED, also known as 石榴云医, successfully went public on NASDAQ with the stock code POM, raising over $20 million by issuing more than 5 million shares at an offering price of $4 per share [6][8] - 石榴云医 is a leading online healthcare service platform in China, focusing on chronic disease management and pharmaceutical services, ranking sixth in the Chinese internet hospital market based on the number of contracted doctors as of 2022 [8] - As of the closing on October 9, 2025, the stock price of 石榴云医 (POM) reached $4.77, giving the company a market capitalization of approximately $565 million [8] Group 2 - The stock experienced a price increase of 19.26% from its initial offering price of $4.00 to $4.77 within the first day of trading [9] - Key financial metrics include a price-to-earnings ratio (TTM) indicating a loss, a price-to-book ratio of -1.78, and an earnings per share of -$0.04 [9] - The total share capital of 石榴云医 is 118 million shares, with a net asset value per share of $17.35 [9]
石榴云医/七乐康，成功在美国纳斯达克上市